Serhat Aras, Tuğba Kul Köprülü, Burçin Erkal Çam, Jülide Balkan, Esra Erdem, Esra Çikler, Altan Kara
{"title":"Transcriptome Analysis of the Effects of X-Ray Radiotherapy on Non-small-cell Lung Cancer Using Next-generation Sequencing.","authors":"Serhat Aras, Tuğba Kul Köprülü, Burçin Erkal Çam, Jülide Balkan, Esra Erdem, Esra Çikler, Altan Kara","doi":"10.21873/invivo.14070","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study investigated the acute effects of flattening filter (FF) and flattening filter-free (FFF) beams on gene expression in non-small-cell lung cancer (NSCLC).</p><p><strong>Materials and methods: </strong>Thirty-six adult athymic nude mice were divided into five groups. The control group did not undergo any radiotherapy or treatment procedures, whereas in the lung cancer (LCa) group, a cancer model was created but not irradiated. LCa models received 20 Gy radiotherapy with FF at 400 MU/min, or with FFF at 1,000 or 1,800 MU/min dose rates. The mice were irradiated 20 days after A549 cancer cell-line implantation and sacrificed 48 h after irradiation for genetic analysis.</p><p><strong>Results: </strong>Twelve genes were identified as being common across all radiotherapy groups. The expression of most of these genes changed as the dose rate increased. Seven of these genes were also common to the LCa and control groups. Three genes down-regulated in the untreated cancer group showed increased expression with higher dose rates in treated groups. Significant differences were observed in glutamatergic synapse, actin cytoskeleton regulation, and steroid synthesis in FF-400 and FFF-1000. The FFF-1800 group exhibited significant changes in RNA transport, actin cytoskeleton regulation, and phagosome-associated pathways.</p><p><strong>Conclusion: </strong>FFF beams induced more extensive and pronounced gene-expression changes compared to FF beams in NSCLC.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 5","pages":"2711-2727"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396078/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14070","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aim: This study investigated the acute effects of flattening filter (FF) and flattening filter-free (FFF) beams on gene expression in non-small-cell lung cancer (NSCLC).
Materials and methods: Thirty-six adult athymic nude mice were divided into five groups. The control group did not undergo any radiotherapy or treatment procedures, whereas in the lung cancer (LCa) group, a cancer model was created but not irradiated. LCa models received 20 Gy radiotherapy with FF at 400 MU/min, or with FFF at 1,000 or 1,800 MU/min dose rates. The mice were irradiated 20 days after A549 cancer cell-line implantation and sacrificed 48 h after irradiation for genetic analysis.
Results: Twelve genes were identified as being common across all radiotherapy groups. The expression of most of these genes changed as the dose rate increased. Seven of these genes were also common to the LCa and control groups. Three genes down-regulated in the untreated cancer group showed increased expression with higher dose rates in treated groups. Significant differences were observed in glutamatergic synapse, actin cytoskeleton regulation, and steroid synthesis in FF-400 and FFF-1000. The FFF-1800 group exhibited significant changes in RNA transport, actin cytoskeleton regulation, and phagosome-associated pathways.
Conclusion: FFF beams induced more extensive and pronounced gene-expression changes compared to FF beams in NSCLC.
期刊介绍:
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.